Valuation: Stryker Corporation

Capitalization 15TCr 13TCr 12TCr 11TCr 20TCr 12,80000Cr 23TCr 1,43500Cr 54TCr 6,00100Cr 56TCr 55TCr 22,06000Cr P/E ratio 2025 *
37x
P/E ratio 2026 * 31.8x
Enterprise value 16TCr 14TCr 13TCr 12TCr 22TCr 13,60400Cr 24TCr 1,52600Cr 58TCr 6,37800Cr 59TCr 58TCr 23,44600Cr EV / Sales 2025 *
6.38x
EV / Sales 2026 * 5.8x
Free-Float
94.53%
Yield 2025 *
0.87%
Yield 2026 * 0.92%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.16%
1 week-0.13%
Current month-1.69%
1 month+4.20%
3 months+14.53%
6 months-1.75%
Current year+8.02%
More quotes
1 week 385.19
Extreme 385.19
393
1 month 372.48
Extreme 372.48
399.74
Current year 329.16
Extreme 329.1608
406.19
1 year 314.93
Extreme 314.93
406.19
3 years 191.88
Extreme 191.88
406.19
5 years 185.2
Extreme 185.2
406.19
10 years 86.68
Extreme 86.68
406.19
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2012
Director of Finance/CFO - 01/04/2025
Chief Tech/Sci/R&D Officer 53 -
Director TitleAgeSince
Director/Board Member 81 01/01/1974
Director/Board Member 70 01/01/1984
Chairman 59 22/07/2014
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.16%-0.13%+17.42%+105.49% 15TCr
+0.49%+0.22%+2.09%-2.89% 1.31TCr
+0.75%+3.29%+3.63%-56.76% 740.23Cr
-0.58%-5.09%-17.00%+100.35% 565.41Cr
-0.88%-2.23%-7.59%-34.81% 377.43Cr
+0.75%-.--%+4.38%+11.85% 362.77Cr
+1.70%+15.93%+67.31%+17.47% 236.3Cr
-0.15%+2.12%+1.01%-16.29% 197.09Cr
-9.49%-16.84%-39.68%-47.60% 176.28Cr
+0.95%+8.73%+7.98%-13.76% 172.34Cr
Average -0.68%-0.83%+3.96%+6.30% 1.9TCr
Weighted average by Cap. -0.15%-0.66%+13.89%+82.10%
See all sector performances

Financials

2025 *2026 *
Net sales 2.48TCr 2.12TCr 1.98TCr 1.84TCr 3.4TCr 2,13200Cr 3.79TCr 24TCr 9.03TCr 1LCr 9.29TCr 9.09TCr 3,67500Cr 2.68TCr 2.3TCr 2.14TCr 2TCr 3.68TCr 2,31100Cr 4.11TCr 26TCr 9.78TCr 1,08300Cr 10TCr 9.86TCr 3,98200Cr
Net income 402.07Cr 344.97Cr 321.42Cr 299.05Cr 551.76Cr 35TCr 616.09Cr 3.88TCr 1.47TCr 16TCr 1.51TCr 1.48TCr 60TCr 465.99Cr 399.82Cr 372.52Cr 346.6Cr 639.48Cr 40TCr 714.04Cr 4.5TCr 1.7TCr 19TCr 1.75TCr 1.71TCr 69TCr
Net Debt 934.02Cr 801.39Cr 746.68Cr 694.72Cr 1.28TCr 80TCr 1.43TCr 9.02TCr 3.41TCr 38TCr 3.5TCr 3.43TCr 1,38600Cr 705.56Cr 605.37Cr 564.04Cr 524.79Cr 968.24Cr 61TCr 1.08TCr 6.81TCr 2.57TCr 28TCr 2.65TCr 2.59TCr 1,04700Cr
More financial data * Estimated data
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (59.8%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (40.2%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2024, the group had 45 production sites worldwide. Net sales are distributed geographically as follows: the United States (75%), Europe/Middle East/Africa (12.8%), Asia/Pacific (8.9%) and other (3.3%).
Employees
53,000
More about the company
Date Price Change Volume
18/25/18 388.86 $ -0.01% 3,79,438
17/25/17 388.90 $ -0.50% 10,39,862
16/25/16 390.87 $ +0.07% 10,67,838
15/25/15 390.59 $ -0.22% 14,32,081
14/25/14 391.46 $ +0.51% 12,66,802

Delayed Quote Nyse, July 18, 2025 at 11:13 pm IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
388.90USD
Average target price
422.71USD
Spread / Average Target
+8.69%
Consensus

Quarterly revenue - Rate of surprise